Path to Progress 5K Run/Walk to be hosted to benefit ABTA's research and patient-family programs

NewsGuard 100/100 Score

Register Today! Proceeds Benefit ABTA's Research and Patient-Family Programs

The American Brain Tumor Association (ABTA) will again host its annual Path to Progress 5K Run/Walk on Saturday, May 22, 2010 at Soldier Field in Chicago.

The Path to Progress has steadily grown over the past five years, attracting nearly 4,500 runners and walkers in 2009. New this year is a 1-mile strut open to any interested participant. Proceeds from the Path to Progress benefit the American Brain Tumor Association's research funding and patient-family education and support programs.

Brain tumors do not discriminate, occurring in people of all ages. This year, nearly 63,000 Americans will be diagnosed with a primary brain tumor, and more than 250,000 with a secondary or metastatic brain tumor. More than 600,000 Americans are currently living with a brain tumor diagnosis.

"While significant progress has been made in treatment and care, a brain tumor continues to be a devastating diagnosis," said ABTA Executive Director Elizabeth Wilson. "Through events like the Path to Progress 5K Run/Walk, ABTA ensures continued funding for critical brain tumor research, as well as desperately needed resources and support for patients and families living with this disease.  Please join us on May 22nd on the Path to Progress toward a brain tumor cure!"

Registration opens at 6:30 a.m. Path to Progress registration and information are available at www.pathtoprogress.org.  Cost: $30 for adults; $28 for CARA members; children ages 4 to 12, $10; children under age 4, free (by May 14, 2010). Early bird registration ($5 discount) ends Jan. 31, 2010.

The 2010 Path to Progress sponsors are: Genentech and Schering-Plough (Presenting sponsors); North Shore Community Bank and the University of Chicago Medical Center (Supporting); Integra Foundation, Johnson Controls, NorthShore University HealthSystem, Northwestern Brain Tumor Institute, NovoCure, and Rush University Medical Center (Official); Area Equipment, Inc. and Radiation Oncology Consultants (Associate) and Pioneer Press, 101.9fm THE MIX and Chicago Athlete (Media).

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Diet's role in fighting vitiligo highlighted in new research